Portland Global Advisors LLC Bristol Myers Squibb CO Transaction History
Portland Global Advisors LLC
- $790 Million
- Q4 2024
A detailed history of Portland Global Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Portland Global Advisors LLC holds 5,419 shares of BMY stock, worth $294,956. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,419
Previous 5,054
7.22%
Holding current value
$294,956
Previous $261,000
17.24%
% of portfolio
0.04%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,741Shares Held
1.57BCall Options Held
28.2MPut Options Held
29.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.23 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.18 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.28 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...